Comparing the Effects of Ganoderma lucidum and Kombucha Mushrooms on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial

This randomized clinical trial compared the effects of Ganoderma lucidum and kombucha mushrooms on glycemic control in patients with type 2 diabetes. After the intervention, there were significant differences among the G. lucidum, kombucha mushroom, and control groups in fasting blood glucose, 2-hour postprandial glucose, and A1C. In the G. lucidum and kombucha mushroom groups, these measures all decreased significantly from baseline to after the intervention. The use of both G. lucidum and kombucha mushrooms was effective in glycemic control, and there was no significant difference in effectiveness between the two. Further studies of different doses and longer follow-up periods may clarify the best use of these substances.